ConductScience.org, home

Paper54693

Hypoxic cell sensitisers in radiotherapy.

Adams GE and 3 others. Lancet, 1976. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Hypoxic cell sensitisers in radiotherapy. Papers, record 54693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/54693

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hypoxic cell sensitisers in radiotherapy.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Adams GEG E
2Dische SS
3Fowler JFJ F
4Thomlinson RHR H

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypoxiaMajor topic
NeoplasmsMajor topic
NitroimidazolesMajor topic
Radiation-Sensitizing AgentsMajor topic
Animals
Clinical Trials as Topic
Drug Evaluation
Drug Evaluation, Preclinical
Humans
In Vitro Techniques
Mice
Neoplasms, Experimental
Oxygen Consumption
Radiotherapy Dosage

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
42453580Prodigiosin in glioblastoma: mechanistic pharmacology and rationale for its development as a radiosensitiser.Front Pharmacol2026https://conductscience.org/library/papers/42453580PubMed
37298933Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers.Molecules2023https://conductscience.org/library/papers/37298933PubMed
35910347The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia.Front Pharmacol2022https://conductscience.org/library/papers/35910347PubMed
30575832Hypoxia-targeted drug delivery.Chem Soc Rev2019https://conductscience.org/library/papers/30575832PubMed
25704387F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.Semin Nucl Med2015https://conductscience.org/library/papers/25704387PubMed
24195777Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.BMC Cancer2013https://conductscience.org/library/papers/24195777PubMed
21606941Targeting hypoxia in cancer therapy.Nat Rev Cancer2011https://conductscience.org/library/papers/21606941PubMed
20178464The role of HIF prolyl hydroxylases in tumour growth.J Cell Mol Med2010https://conductscience.org/library/papers/20178464PubMed
7426325A drug for improved radiosensitization in radiotherapy.Br J Cancer1980https://conductscience.org/library/papers/7426325PubMed
7138762The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process.Br J Cancer1982https://conductscience.org/library/papers/7138762PubMed
6678963Evoked potentials in rats with misonidazole neurotoxicity. I. Brain stem auditory evoked potentials.J Neurooncol1983https://conductscience.org/library/papers/6678963PubMed
2145963Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.Br J Cancer1990https://conductscience.org/library/papers/2145963PubMed
198056Metronidazole neuropathy.Br Med J1977https://conductscience.org/library/papers/198056PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/54693

GET https://conductscience.org/api/papers/v1/54693/authors